Results 221-240 of 335 for 5 million speaker:Simon Harris

Health Insurance (Amendment) Bill 2017 [Seanad]: Second Stage (30 Nov 2017)

Simon Harris: ...tries to ensure equity and fairness, which I believe is reflected by a societal belief that is held across the State. The number of people who currently hold private health insurance is more than 2.1 million, with three commercial insurers operating within the market. There is, however, a clear disparity in the membership profile and thus the associated costs being incurred across the...

Written Answers — Department of Health: Medical Card Drugs Availability (29 Nov 2017)

Simon Harris: ...and effectively. This requires an integrated approach to secure best value for money for all treatments, greater efficiencies in the supply chain and the use of the most cost-effective treatments. Lidocaine 5% medicated plaster (Versatis) is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic...

Written Answers — Department of Health: Medical Aids and Appliances Provision (28 Nov 2017)

Simon Harris: ...and effectively. This requires an integrated approach to secure best value for money for all treatments, greater efficiencies in the supply chain and the use of the most cost-effective treatments. Lidocaine 5% medicated plaster (Versatis) is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia...

Ceisteanna - Questions (Resumed) - Priority Questions: Emergency Departments (15 Nov 2017)

Simon Harris: ...a reality and take some services out of our acute hospitals and put them into primary care. I opened a primary care centre in Castlebar, County Mayo, last Friday. In April of this year, there were 517 people were awaiting X-rays at Mayo General Hospital. That figure has now been reduced to zero as a result of the decision to provide such facilities in the primary care system. By the end...

Written Answers — Department of Health: Hospital Overcrowding (15 Nov 2017)

Simon Harris: ...conditions in some of our hospital Emergency Departments. This year so far, Emergency Department attendances are up over 1.8% or over 16,000 patients by the end of September, including a 5% increase in Emergency Department attendances by people over 75 years. Within this context, trolley numbers and patient experience times are showing small improvements on this time last year. As of...

Written Answers — Department of Health: Medicinal Products Reimbursement (14 Nov 2017)

Simon Harris: ...and effectively. This requires an integrated approach to secure best value for money for all treatments, greater efficiencies in the supply chain and the use of the most cost-effective treatments. Lidocaine 5% medicated plaster (Versatis) is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia...

Written Answers — Department of Health: Hospitals Policy (7 Nov 2017)

Simon Harris: Tackling overcrowding in Emergency Departments (EDs) is a key commitment of this Government and I am delighted that €40 million in additional funding in 2017 has been made available as part of the 2018 Budget to address winter pressures and waiting lists over the rest of this year. This funding will be aimed at reducing overcrowding in our hospitals in this period through the...

Written Answers — Department of Health: Medical Card Drugs Availability (7 Nov 2017)

Simon Harris: I propose to take Questions Nos. 755 and 761 together. Medicines play a vital role in improving the health of Irish patients. Securing access to existing and new and innovative medicines is a key objective of the health service. However, the challenge is to do this in an affordable and sustainable manner. The medicines bill for the community drugs schemes – primarily the GMS, Long...

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Simon Harris: ...engaged in contractual discussions with GPs. I have made it very clear - I will make it very clear again - that the totality of those discussions should not be seen to merely relate to the €25 million primary care fund in the budget. GPs have issues they want to discuss as part of the contract negotiations. I have issues that I want to discuss and that is the mechanism whereby we...

Written Answers — Department of Health: Medical Card Drugs Availability (18 Oct 2017)

Simon Harris: ...and effectively. This requires an integrated approach to secure best value for money for all treatments, greater efficiencies in the supply chain and the use of the most cost-effective treatments. Lidocaine 5% medicated plaster (Versatis) is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia...

Written Answers — Department of Health: Medicinal Products Availability (12 Oct 2017)

Simon Harris: ...and effectively. This requires an integrated approach to secure best value for money for all treatments, greater efficiencies in the supply chain and the use of the most cost-effective treatments. Lidocaine 5% medicated plaster (Versatis) is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia...

Financial Resolutions 2018 - Financial Resolution No. 1: Tobacco Products Tax (10 Oct 2017)

Simon Harris: .... We have the Tobacco Free Ireland policy, which includes a number of policy and legislative proposals aimed at reducing the prevalence of smoking. The aim is to have a tobacco-free Ireland by 2025. There are more than 60 recommendations, all aimed at denormalising smoking in society so that less than 5% of the population is smoking by 2020. As part of Tobacco Free Ireland, my...

Written Answers — Department of Health: General Medical Services Scheme (10 Oct 2017)

Simon Harris: ...of medicines in Ireland. The MMP has undertaken a number of initiatives to improve evidence-based and cost-effective prescribing nationally and the review of Versatis is an example of this. Versatis 5% medicated plaster is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia (PHN), in adults....

Written Answers — Department of Health: National Treatment Purchase Fund Data (10 Oct 2017)

Simon Harris: ...that this places on patients and their families. Reducing waiting times for the longest waiting patients is one of this Government's key priorities. Consequently, Budget 2017 allocated €20 million to the NTPF, rising to €55 million in 2018. Of this 2017 allocation, €15 million has been set aside for the treatment of those patients waiting longest for inpatient and day...

Written Answers — Department of Health: Medicinal Products Availability (3 Oct 2017)

Simon Harris: I propose to take Questions Nos. 304, 315 and 321 together. Medicines play a vital role in improving the overall health of Irish patients. Securing access to existing and new and innovative medicines, is a key objective of the Irish health service. However, the challenge is to deliver this objective in an affordable and sustainable manner. The medicines bill for the community drugs schemes -...

Written Answers — Department of Health: Rare Diseases Strategy (3 Oct 2017)

Simon Harris: A ‘rare disease’ is defined in Europe as a life-threatening or chronically debilitating disease affecting no more than 5 people per 10,000. There are an estimated 6,000-8,000 known rare diseases affecting up to 6% of the total EU population (at least 30 million Europeans). The term Ehlers-Danlos syndrome does not characterise a disease but a group of diseases. However,...

Written Answers — Department of Health: Medicinal Products Availability (21 Sep 2017)

Simon Harris: I propose to take Questions Nos. 158 and 159 together. Medicines play a vital role in improving the overall health of Irish patients. Securing access to existing and new and innovative medicines, is a key objective of the Irish health service. However, the challenge is to deliver this objective in an affordable and sustainable manner. The medicines bill for the community drugs schemes...

Written Answers — Department of Health: Health Services Data (20 Sep 2017)

Simon Harris: ...indicative annual cost for GP visit card eligibility and medical card eligibility, by age group. Indicative Annual Cost per Card Age Group GP Visit Card Medical Card 0 – 4 Yrs €243 €392 5 – 15 Yrs €163 €214 16 - 44 Yrs €149 €595 45 – 64 Yrs €221 €1,217 65 – 69 Yrs €250 €1,602 Aged 70...

Written Answers — Department of Health: Medical Card Drugs Availability (20 Sep 2017)

Simon Harris: .... The Medicines Management Programme has undertaken a number of initiatives aimed at enhancing evidence-based and cost-effective prescribing nationally and the review of Versatis is an example of this. Versatis 5% medicated plaster is licensed for the symptomatic relief of neuropathic pain associated with previous herpes zoster (shingles) infection, known as post-herpetic neuralgia...

Written Answers — Department of Health: General Practitioner Services Provision (13 Jul 2017)

Simon Harris: ...annual cost for GP visit card eligibility and medical card eligibility, by age group. Indicative Annual Cost per Card Age Group GP Visit Card Medical Card 0 – 4 Yrs €243 €392 5 – 15 Yrs €163 €214 16 - 44 Yrs €149 €595 45 – 64 Yrs €221 €1,217 65 – 69 Yrs €250 ...